B Positive Plasma
B Positive Plasma is a privately held plasma collection company operating 11-12 donation centers across Pennsylvania, New Jersey, and Delaware. It supplies plasma to biopharmaceutical manufacturers for life-saving therapies while compensating individual donors via a proprietary Visa debit card and rewards program.
- Company typePrivate
- Founded2010
- HeadquartersCherry Hill, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What B Positive Plasma does
B Positive Plasma is a privately held plasma collection company that operates physical donation centers where individual donors sell plasma that is subsequently processed by biopharmaceutical manufacturers into life-saving therapies for rare and chronic conditions including Primary Immune Deficiency, Alpha-1, and Hemophilia. Founded in 2010 and headquartered in Cherry Hill, New Jersey, the company is structured as B Positive Plasma LLC and operates as a subsidiary of B Positive National Blood Services. As of the available data, it runs 11-12 donation centers across Pennsylvania (Cheltenham, Bethlehem, City Ave/Merion Station, Easton, Holmes, Scranton, Edwardsville/Wilkes-Barre, Wyoming), New Jersey (Atlantic City, Bloomfield, Egg Harbor Township), and Delaware (Wilmington), with an additional walk-in-capable site at Aramingo Avenue in Philadelphia referenced in operational communications.
The company's core technology is standard plasmapheresis equipment that separates plasma from blood components and returns red blood cells to the donor via the same needle, enabling donors to give up to twice per week. Its product platform is unified around a donor-centric service model: donors schedule appointments online, complete a brief medical screening, donate (taking approximately 90 minutes), and receive compensation through a proprietary B Positive Visa Debit Card issued at first donation. Supporting programs include the New Donor Rewards Program (over $800 in first-month earnings for new donors, up to $135 weekly thereafter) and a Refer a Friend program paying $10 per successful referral.
B Positive Plasma generates revenue by collecting plasma and supplying it to the biopharmaceutical industry under a transaction-fee model, while paying donors usage-based compensation that varies by location, donor tenure, and promotional period. Its primary customer segment is middle-class Americans seeking supplemental income to cover expenses such as rent, medical bills, and childcare, though it explicitly accepts donors of all blood types despite the company name. The company competes in the U.S. plasma collection market — an industry that generates $4.7 billion in annual payments, supplies approximately 70% of the world's plasma, and has seen a 30% increase in collections since 2022 — against larger national operators including CSL Plasma, BioLife, and Grifols.
B Positive Plasma firmographics
Firmographics- Name
- B Positive Plasma
- Legal name
- B Positive Plasma LLC
- Website
- https://bpositivetoday.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- B Positive Plasma is a privately held plasma collection company operating 11-12 donation centers across Pennsylvania, New Jersey, and Delaware. It supplies plasma to biopharmaceutical manufacturers for life-saving therapies while compensating individual donors via a proprietary Visa debit card and rewards program.
- Ownership category
- akta.pro rank
B Positive Plasma industry classification
Industry- Product category
- Blood Plasma Collection Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)
- akta.pro secondary industries
- Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI), Plasma-Derived Therapy Cold Chain & Specialty Logistics (HLAIAHAL), Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
Keywords
Where B Positive Plasma is headquartered
LocationHeadquarters
- HQ city
- Cherry Hill
- HQ country
- United States
- HQ region
- North America
Offices12 records
Markets served
B Positive Plasma business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Plasma Collection and Sale: B Positive Plasma collects plasma from donors at its collection centers. The plasma is processed by biopharmaceutical companies into life-saving medicines and treatments that are exported globally. The company generates revenue by supplying plasma to the medical/pharmaceutical industry.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Monthly | New Donor First Month Earning Potential |
| Usage-based | Weekly | Regular Repeat Donor Weekly Earning Potential |
| Transaction based/ take rate | Pay-as-you-go | Referral Bonus |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
B Positive Plasma product offering
Product offeringCore offering
B Positive Plasma operates physical plasma donation centers across Pennsylvania, New Jersey, and Delaware where individual donors undergo plasmapheresis procedures to supply source plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into life-saving vaccines and therapies for rare and chronic diseases. Donors are compensated for their time via a reloadable B Positive Visa Debit card, with new donors eligible for $800+ in their first month and regular donors able to earn up to $135 per week.
Product overview
B Positive Plasma operates a unified plasma donation service platform comprising 11 collection centers across Pennsylvania, New Jersey, and Delaware. The core offering is plasma collection with donor compensation via the B Positive Visa Debit Card. Supporting offerings include the New Donor Rewards Program providing new donors over $800 in their first month and regular donors up to $135 weekly, plus the Refer a Friend Program paying $10 per referral. Donors can donate plasma up to twice weekly with visits taking approximately 90 minutes. The company positions itself as a donor-focused service contributing plasma to biopharmaceutical companies for life-saving treatments and vaccines.
Differentiator
Problem solved
Functional benefit
Products and services
- Plasma Donation Service Core service in which individual donors visit a B Positive Plasma donation center in PA, NJ, or DE and undergo plasmapheresis to supply blood plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into vaccines and therapies for rare and chronic diseases. Open to donors of all blood types with new donor compensation of $800+ in the first month and up to $135 per week for regular donors.
- B Positive Visa Debit Card
Quantifiable outcome
- 130 donations needed to treat one patient with Primary Immune Deficiency for one year
- +2 more outcomes
Companies that use B Positive Plasma
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
B Positive Plasma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
B Positive Plasma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- B Positive National Blood ServicescoreB Positive Plasma operates as a B Positive National Blood Services company, indicating it is part of a national network of blood services organizations.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
B Positive Plasma competitors and assessment
Company assessmentOthers
- Haemonetics: Supplier of plasmapheresis equipment and blood component collection technology used across the plasma industry. Not a collector, but its products are core to B Positive's operating model and its commercial performance signals industry-wide collection trends.
Broad incumbents
- Versiti: Large nonprofit blood and plasma collector operating across multiple states. Comparable donor collection operations and regulatory framework, though nonprofit-driven rather than for-profit; relevant for understanding institutional buyer-supplier dynamics.
Direct peers
- ImmunoTek Bio Centers: Privately held US plasma collection company operating 30+ centers. Closest size comp to B Positive as an independent, multi-center collector without vertical fractionation integration.
- Grifols Plasma: Plasma collection arm of Grifols, one of the three global fractionators, operating 100+ US centers. Directly comparable business model and regulatory regime; competes for the same donor pool and operates its own fractionation downstream.
- ADMA BioCenters: Plasma collection subsidiary of ADMA Biologics, operating FDA-licensed centers that supply raw plasma for its proprietary immune globulin products. Comparable regulated plasma collection operations and donor-driven GTM.
- BioLife Plasma Services: Subsidiary of Takeda Pharmaceutical, operating ~140 plasma donation centers across the US. Comparable donor compensation model, FDA-regulated plasmapheresis operations, and direct competitor for both donors and downstream fractionation buyers.
- CSL Plasma: Subsidiary of CSL Behring and the world's largest plasma collection network with 300+ US centers. Directly comparable as a for-profit plasma collection business selling raw plasma to a vertically integrated fractionator; same donor model, same regulatory framework.
- Octapharma Plasma: US plasma collection subsidiary of Octapharma AG, operating 90+ centers. Same for-profit collection model, same donor compensation structure, and competes with B Positive for donors in overlapping geographies.
- Kedrion Biopharma (KEDPlasma): US plasma collection operations of Kedrion Biopharma. Comparable for-profit plasma collection business model with center-based donor acquisition and similar regulatory and operational footprint.
Emerging players
- Interstate Blood Bank (IBBI): Smaller US plasma and blood products collector. Comparable center-based collection model but smaller scale; provides a peer benchmark for sub-scale operators in the same industry.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
B Positive Plasma social profiles
Digital presenceB Positive Plasma financial estimates
Financial estimateRevenue estimate
Valuation estimate
B Positive Plasma leadership team
Management profileNumber of profiles
Profiles1 record
B Positive Plasma funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
B Positive Plasma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about B Positive Plasma
What does B Positive Plasma do?
B Positive Plasma operates physical plasma donation centers across Pennsylvania, New Jersey, and Delaware where individual donors undergo plasmapheresis procedures to supply source plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into life-saving vaccines and therapies for rare and chronic diseases. Donors are compensated for their time via a reloadable B Positive Visa Debit card, with new donors eligible for $800+ in their first month and regular donors able to earn up to $135 per week.
Is B Positive Plasma a public or private company?
B Positive Plasma is a private company. It is classified as corporate owned and is currently operating.
When was B Positive Plasma founded?
B Positive Plasma was founded in 2010. It employs 101 to 250 people.
Where is B Positive Plasma based?
B Positive Plasma is headquartered in Cherry Hill, United States, in the North America region.
How does B Positive Plasma make money?
One revenue line is on record: plasma Collection and Sale.
Who are B Positive Plasma's main competitors?
Haemonetics is listed as an others. Versiti is listed as a broad incumbent. Direct peers are ImmunoTek Bio Centers, Grifols Plasma, ADMA BioCenters, BioLife Plasma Services, CSL Plasma, Octapharma Plasma and Kedrion Biopharma (KEDPlasma). Interstate Blood Bank (IBBI) is listed as an emerging player.
Does B Positive Plasma have an API?
No public API is recorded for B Positive Plasma.
What industry is B Positive Plasma in?
B Positive Plasma's product category is Blood Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of HLAAAAAI, Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors). Its NAICS code is 621991 and its SIC code is 5047.